Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38836L |
Protease-Activated Receptor-1, PAR-1 Agonist acetate
|
Protease-activated Receptor | GPCR/G Protein |
Protease-Activated Receptor-1, PAR-1 Agonist acetate 是一种选择性蛋白酶激活受体 1 (PAR-1) 激动剂肽。 它对应于 PAR1 栓系配体,可以选择性地模拟凝血酶通过该受体的作用。 | |||
T8917 |
PAR-2-IN-1
IUN76750,8-(叔丁基)-6-氯咪唑并[1,2-B]吡啶-2-羧酸甲酯 |
Protease-activated Receptor | GPCR/G Protein |
PAR-2-IN-1 (IUN76750) 是一种 PAR-2 信号通路抑制剂,具有抗炎和抗癌作用。 | |||
T36293 |
PAR 4 (1-6)
|
||
PAR 4 (1-6) 可用于生命科学领域的相关研究。其产品编号为 T36293,CAS号为 225779-44-2。 | |||
T38836 |
Protease-Activated Receptor-1, PAR-1 Agonist
|
||
Protease-Activated Receptor-1 (PAR-1) Agonist, a selective peptide, activates the PAR-1 receptor by mimicking the specific actions of thrombin. It corresponds to the PAR1 tethered ligand, facilitating selective activation of this receptor. | |||
T36288 |
Protease-Activated Receptor-1, PAR-1 Agonist TFA
|
||
Protease-Activated Receptor-1 (PAR-1) Agonist TFA is a selective peptide that acts as an agonist for the proteinase-activated receptor-1 (PAR-1). Corresponding to the tethered ligand of PAR-1, this compound mimics the actions of thrombin through the PAR-1 receptor[1][2]. | |||
T7625 |
TRAP-6
PAR-1 agonist peptide,Thrombin Receptor Activator Peptide 6,TRAP-6(2TFA) |
Protease-activated Receptor | GPCR/G Protein |
TRAP-6 (Thrombin Receptor Activator Peptide 6) 是一种多肽片段,是选择性的蛋白酶激活受体 1 (PAR1) 激动剂,通过凝血酶受体激活人血小板。 | |||
T1986 |
Atopaxar
E5555,ER-172594-00 |
Protease-activated Receptor | GPCR/G Protein |
Atopaxar (E5555) 是一种高效、可口服的,选择性的,可逆的凝血酶受体蛋白酶激活受体-1 (PAR-1) 拮抗剂。它是一种抗血小板剂,能干扰血小板信号,可用于动脉粥样硬化血栓性疾病的研究。 | |||
T36286 |
Protease-Activated Receptor-3 (PAR-3) (1-6), human
|
||
TFRGAP-amide, human PAR-3-derived tethered ligand sequence which does not activate PAR-3 but rather activates PAR-1 and PAR-2, either in Jurkat or in other PAR-expressing cells. | |||
T36289 |
Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA
|
||
Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA is a peptide that acts as an agonist for the proteinase-activated receptor (PAR-3)[1]. | |||
T36531 |
PAR2 (1-6) (mouse, rat)
PAR2 (1-6) (mouse, rat) |
||
PAR2 (1-6) is a synthetic peptide agonist of proteinase-activated receptor 2 (PAR2) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of mouse and rat PAR2. It also corresponds to residues 39-44 and 37-42 of the mouse and rat full-length sequences, respectively. PAR2 (1-6) induces relaxation in precontracted rat arteries in a concentration-dependent manner, an effect that can be reduced by the nitric oxide synthase inhibitor L-NNA . It inhibits keratinocyte growth i... | |||
T7623L |
PAR-4 Agonist Peptide, amide acetate
PAR-4 Agonist Peptide, amide acetate(352017-71-1 free base) |
Protease-activated Receptor | GPCR/G Protein |
PAR-4 Agonist Peptide, amide acetate 是蛋白酶激活受体 4 (PAR-4) 的激动剂。 | |||
T35955 |
PAR2 (1-6) amide (human) (trifluoroacetate salt)
PAR2 (1-6) amide (human) (trifluoroacetate salt) |
||
PAR2 (1-6) amide is a synthetic peptide agonist of proteinase-activated receptor 2 (PAR2) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of human PAR2 and residues 37-42 of the full-length sequence.1It binds to NCTC 2544 cells expressing human PAR2 (Ki= 9.64 μM in a radioligand binding assay) and induces calcium mobilization in the same cells (EC50= 0.075 μM).2PAR2 (1-6) amide (100 μM) reduces colony formation of A549 lung cancer cells.1It induces superoxide prod... | |||
T1986L |
Atopaxar Hydrobromide
|
Protease-activated Receptor | GPCR/G Protein |
Atopaxar hydrobromide 是可口服的,高效选择性的可逆凝血酶受体蛋白酶激活受体-1 拮抗剂。它是一种抗血小板剂,能干扰血小板信号,用于动脉粥样硬化血栓性疾病的研究。 | |||
T76650 |
PAR-2 (1-6) (human)
|
||
PAR-2 (1-6) (human) (SLIGKV) 是 PAR-2的多肽激动剂。 | |||
T75904 |
PAR 4 (1-6) (TFA)
|
||
GYPGQV TFA (PAR 4 (1-6) TFA) 是一种六肽,作为蛋白酶激活受体 4 (PAR4) 片段,能特异性抑制PAR4。 | |||
TP1065 |
PAR-4 Agonist Peptide, amide TFA
PAR-4-AP (TFA),AY-NH2 (TFA) |
Protease-activated Receptor | GPCR/G Protein |
PAR-4 Agonist Peptide, amide TFA (PAR-4-AP (TFA)) 是一种蛋白酶激活受体 4 (PAR-4) 激动剂,对 PAR-1 或 PAR-2 均无影响,其作用可被 PAR-4 拮抗剂阻断。 | |||
T38852L |
TRAP-6 amide acetate
|
Protease-activated Receptor | GPCR/G Protein |
TRAP-6 amide acetate 是一种 PAR-1 凝血酶受体激动剂肽。 | |||
T3098 |
Vorapaxar sulfate
SCH 530348 sulfate,Zontivity,vorapaxar monosulfate,沃拉帕沙 |
Protease-activated Receptor | GPCR/G Protein |
Vorapaxar sulfate (Zontivity) 是一种选择性、口服活性和竞争性的凝血酶受体蛋白酶激活受体(PAR-1)拮抗剂,Ki 值为 8.1 nM。它剂量依赖性抑制凝血酶受体激活肽 (TRAP) 诱导的血小板聚集,是抗血小板药物。 | |||
T7013 |
Vorapaxar
SCH 530348,MK-5348,沃拉帕沙 |
Protease-activated Receptor | GPCR/G Protein |
Vorapaxar (MK-5348) 是抗血小板药物,是一种选择性、口服活性和竞争性的凝血酶受体蛋白酶激活受体(PAR-1)拮抗剂,Ki 值为 8.1 nM。它靠剂量依赖性抑制凝血酶受体激活肽 (TRAP) 诱导的血小板聚集。 | |||
T80240 |
Ala-parafluoroPhe-Arg-Cha-Cit-Tyr-NH2
|
||
Ala-parafluoroPhe-Arg-Cha-Cit-Tyr-NH2是一类具有生物活性的肽,作为蛋白酶激活受体1 (PAR-1) 的选择性激动剂,其特异性优于PAR-2。该肽通过HEK293细胞进行的基于细胞的钙信号传导测定确认了其对PAR-1的高特异性,并可用于研究PAR-1在体内的激活。PAR-1除了介导凝血酶的多种细胞作用外,还与PAR-4协作,参与调控凝血酶诱导的被分类为“凝血型”的肝细胞癌。 | |||
T80236 |
TFLLRN-NH2
|
||
TFLLRN-NH2 为具备生物活性的肽类化合物,作用为PAR-1激动剂。 | |||
T7623 |
PAR-4 Agonist Peptide, amide
AY-NH2,PAR-4 Agonist Peptide, amide(2TFA),PAR-4-AP |
Protease-activated Receptor | GPCR/G Protein |
PAR-4 Agonist Peptide, amide (AY-NH2) 是蛋白酶激活受体 4 (PAR-4) 的激动剂,对 PAR-1 或 PAR-2 均无影响,其作用可被 PAR-4 拮抗剂阻断。 | |||
T38852 |
TRAP-6 amide
|
||
TRAP-6 amide is a PAR-1 thrombin receptor agonist peptide. | |||
T38887 |
TRAP-6 amide TFA
|
||
TRAP-6 amide TFA is a PAR-1 thrombin receptor agonist peptide. | |||
T22036 |
Arylquin 1
|
||
Arylquin 1 是一种前列腺-凋亡-反应-4(Par-4)促分泌剂,靶向波形蛋白诱导 Par-4 分泌。Arylquin 1 通过诱导溶酶体膜通透性 (LMP) 诱导癌细胞非凋亡性细胞死亡。 | |||
T75873 |
Parstatin(human) TFA
|
||
Parstatin(human) TFA 是具有细胞通透性的 PAR-1凝血酶受体的肽类激动剂,是一种有效的血管生成抑制剂。 | |||
T75872 |
Parstatin(mouse) TFA
|
||
Parstatin(mouse) TFA 是具有细胞通透性的 PAR-1凝血酶受体的肽类激动剂,是一种有效的血管生成抑制剂。 | |||
T75902 |
SLIGRL-NH2 TFA
Protease-Activated Receptor-2 Activating Peptide TFA |
||
SLIGRL-NH2 TFA(Protease-Activated Receptor-2 Activating Peptide TFA)作为PAR-2(蛋白酶激活受体-2)的激动剂,具有高度特异性。 | |||
T80239 |
TFLLRNPNDK-NH2
|
Thrombin | Proteases/Proteasome |
TFLLRNPNDK-NH2 是具备生物活性的肽类化合物,作为凝血酶受体激活肽(PAR-1 激动剂肽)能够可逆地与 PAR-1 结合,模拟凝血酶对底物蛋白通过水解作用产生的“束缚配体”。同凝血酶的作用相似,此肽能够增加液体与蛋白质的渗透性。 | |||
T80111 |
TRAP-5 amide
|
||
TRAP-5 amide为蛋白酶激活受体1(PAR1)特异性的激动剂肽。 | |||
T62507 | Protease-Activated Receptor-1 antagonist 1 | ||
Protease-Activated Receptor-1 antagonist 1 (Compound 13) 是一种蛋白酶激活受体 1 (PAR-1) 拮抗剂,通过 FLIPR 技术得到的 IC50 为 3 nM。Protease-Activated Receptor-1 antagonist 1 能够用于研究血栓性心血管、心肌梗塞和外周动脉疾病。 | |||
T78099 |
iso-TRAP-6
iso-SFLLRN |
||
iso-TRAP-6(iso-SFLLRN)为PAR-1激动剂,具备激活血小板的能力。该化合物作为TRAP-6的同系物,通过以异丝氨酸替换丝氨酸成为首位氨基酸而构成。 | |||
T64285 | Protease-Activated Receptor-1 antagonist 2 | ||
Protease-Activated Receptor-1 antagonist 2 是一种选择性的、口服具有活力的蛋白酶激活受体-1 (PAR-1) 拮抗剂 (IC50: 7 nM)。Protease-Activated Receptor-1 antagonist 2 显示出良好的药代动力学特性,能够用于进行心血管疾病 (CVD) 的相关研究(如动脉粥样硬化和再狭窄)。 | |||
T36717 |
RWJ-56110 dihydrochloride
|
||
RWJ-56110 dihydrochloride is a potent, selective, peptide-mimetic inhibitor of PAR-1 activation and internalization (binding IC50=0.44 uM) and shows no effect on PAR-2, PAR-3, or PAR-4. RWJ-56110 dihydrochloride inhibits the aggregation of human platelets induced by both SFLLRN-NH2 (IC50=0.16 μM) and thrombin (IC50=0.34 μM), quite selective relative to U46619 . RWJ-56110 dihydrochloride blocks angiogenesis and blocks the formation of new vessels in vivo. RWJ-56110 dihydrochloride induces cell ap... | |||
T80235 |
YFLLRNP
|
||
YFLLRNP 是 PAR-1 部分激动剂,具有生物活性。它在低浓度下选择性地激活 G12/13 信号通路,而不会对 Gq 或 Gi 通路产生影响(60 μM)。 | |||
T74266 |
Protease-Activated Receptor-1 antagonist 2
|
||
Protease-Activated Receptor-1 antagonist 2 是一种选择性蛋白酶激活受体-1 (PAR-1) 拮抗剂,口服活性,IC50值为7 nM。该化合物具有优良的药代动力学特性,适用于心血管疾病 (CVD) 如动脉粥样硬化和再狭窄的研究。 | |||
T80502 |
P4pal10
|
||
P4pal10为PAR4拮抗剂,能在体内抑制凝血酶介导的小鼠血小板聚集,并显著减少Carrageenan引起的水肿及粒细胞浸润。 | |||
T79265 |
Antitumor agent-104
|
PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair |
Antitumor agent-104(Compound 9)是一种作用机制为抑制肿瘤中DNA损伤修复的抗肿瘤剂。该化合物能够抑制PARP1酶的活性及降低PAR蛋白的水平,并且还能够抑制CDK12的表达。 | |||
T74511 | TFMU-ADPr triethylamine | ||
TFMU-ADPr triethylamine 作为监测聚 ATP-核糖糖水解酶 (PARG) 活性的标准底物,能够通过释放荧光团直接报告 PAR 水解酶的总活性。其特点包括高反应性、广泛的通用性、稳定性以及便于使用,使其成为体外评估小分子抑制剂以及研究 ATP-核糖基分解代谢酶调控的优选工具。 | |||
T74510 |
TFMU-ADPr
|
||
TFMU-ADPr作为监测聚ATP-核糖糖水解酶(PARG)活性的底物,以其释放的荧光团直接反映PAR水解酶总活性而常用。该化合物因具备优良的反应性、通用性、稳定性及易用性,成为体外评估小分子抑制剂及研究ATP-核糖基分解代谢酶调控的首选工具。 |